文献速递乳腺甲状腺与浅表US

浸润性小叶癌与浸润性导管癌腋窝淋巴结转移的超声检测与形态比较

Axillary Nodal Metastases in Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma: Comparison of Node Detection and Morphology by Ultrasound.
PubMed 文献 · AJR Am J Roentgenol · 2021-07-28

这项回顾性研究纳入695例女性乳腺癌患者(723个患乳),比较浸润性小叶癌与浸润性导管癌腋窝转移淋巴结的超声检出率及形态特征。结果显示小叶癌超声检出率低于导管癌(80.3% vs 88.7%,p=.04),且小叶癌转移淋巴结更常见弥漫性皮质增厚而较少累及门部。提示对小叶癌患者或需降低超声可疑腋窝淋巴结的活检阈值。

要点

  • 小叶癌腋窝转移淋巴结超声检出率低于导管癌(80.3% vs 88.7%)。
  • 小叶癌转移淋巴结更常表现为弥漫性皮质增厚、门部占位效应不明显。
  • 小叶癌中超声可见的转移淋巴结更多为3个以上异常(50.8%)且尺寸≤2.0cm(65.6%)。

关键影像表现/征象

  • 小叶癌转移淋巴结超声上更常见弥漫性皮质增厚而无门部占位效应(III/IV型占68.9%),导管癌则以明显皮质增厚伴门部占位效应(V/VI型)更常见(占28.8%)。
  • 小叶癌中超声可见的转移淋巴结尺寸≤2.0cm者占65.6%,导管癌为47.3%。
  • 小叶癌中超声可见的转移淋巴结≥3个异常者占50.8%,导管癌为69.2%。

诊断标准与关键数值

  • 超声检出转移淋巴结的比例:小叶癌80.3%,导管癌88.7%(p=.04)。
  • 形态分型观察者间一致性kappa系数为0.63(95%CI 0.54-0.73)。

临床应用与阅片要点

  • 对小叶癌患者,超声发现可疑腋窝淋巴结时应考虑降低活检阈值。
  • 注意小叶癌转移淋巴结可表现为弥漫性皮质增厚而门部结构似保留,避免漏诊。
  • 评估淋巴结形态时注意观察者间一致性仅为中等,需结合多参数判断。

局限性

  • 回顾性单中心研究设计。
  • 形态分型仅在部分病例(241例)中评估观察者间一致性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Invasive lobular carcinoma is more subtle on imaging compared with invasive ductal carcinoma; nodal metastases may also differ on imaging between these two. OBJECTIVE. The purpose of this study was to determine whether invasive lobular carcinoma and invasive ductal carcinoma differ in the detection rate by ultrasound (US) of metastatic axillary nodes and in the metastatic nodes' US characteristics. METHODS. This retrospective study included 695 women (median age, 53 years) who had breast cancer in a total of 723 breasts (76 lobular, 586 ductal, 61 mixed ductal and lobular histology) with biopsy-proven axillary nodal metastases and who underwent pretreatment US. A single breast radiologist reviewed US images in patients with suspicious nodes on US and classified number of nodes, size, and morphology. Morphologic assessment used a previously described classification according to the relationship between node cortex and hilum. Nodal findings were compared between lobular and ductal carcinoma. A second radiologist independently classified node morphology in 241 cancers to assess interreader agreement. RESULTS. A total of 99 metastatic axillary nodes (15 lobular, 66 ductal, 18 mixed histology) were not visualized on US and were diagnosed by surgical biopsy. The remaining 624 metastatic nodes (61 lobular, 520 ductal, 43 mixed ductal and lobular histology) were visualized on US and diagnosed by US-guided fine-needle aspiration. US detected the metastatic nodes in 80.3% for lobular carcinoma versus 88.7% for ductal carcinoma (p = .04). Among metastatic nodes detected by US, retrospective review identified three or more abnormal nodes in 50.8% of lobular carcinoma versus 69.2% of ductal carcinoma (p = .003); node size was 2.0 cm or smaller in 65.6% for lobular carcinoma versus 47.3% for ductal carcinoma (p = .03); morphology was type III or IV (diffuse cortical thickening without hilar mass effect) rather than type V or VI (marked cortical thickening with hilar mass effect) in 68.9% for lobular carcinoma versus 28.8% for ductal carcinoma (p < .001). Interreader agreement assessment for morphology exhibited a kappa coefficient of 0.63 (95% CI, 0.54-0.73). CONCLUSION. US detects a lower percentage of nodal metastases in lobular than in ductal carcinoma. Nodal metastases in lobular carcinoma more commonly show diffuse cortical thickening and with less hilar mass effect. CLINICAL IMPACT. A lower threshold may be warranted to recommend biopsy of suspicious axillary nodes detected on US in patients with lobular carcinoma.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Chung HL, Tso HH, Middleton LP, et al. Axillary Nodal Metastases in Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma: Comparison of Node Detection and Morphology by Ultrasound. AJR Am J Roentgenol. 2021. PMID: 34319162. doi:10.2214/AJR.21.26135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。